CEMTREX INC (CETX)

US15130G7097 - Common Stock

3.06  +0.03 (+0.99%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CETX. CETX was compared to 127 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of CETX have multiple concerns. CETX has a correct valuation and a medium growth rate.



1

1. Profitability

1.1 Basic Checks

CETX had negative earnings in the past year.
CETX had a negative operating cash flow in the past year.
CETX had negative earnings in each of the past 5 years.
In the past 5 years CETX reported 4 times negative operating cash flow.

1.2 Ratios

CETX has a Return On Assets of -9.82%. This is in the lower half of the industry: CETX underperforms 69.05% of its industry peers.
CETX's Return On Equity of -65.85% is on the low side compared to the rest of the industry. CETX is outperformed by 81.75% of its industry peers.
Industry RankSector Rank
ROA -9.82%
ROE -65.85%
ROIC N/A
ROA(3y)-20.93%
ROA(5y)-26.96%
ROE(3y)-83.87%
ROE(5y)-80.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of CETX (43.14%) is better than 77.78% of its industry peers.
CETX's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CETX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.26%
GM growth 5Y3.58%

0

2. Health

2.1 Basic Checks

CETX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CETX has more shares outstanding
The number of shares outstanding for CETX has been increased compared to 5 years ago.
The debt/assets ratio for CETX is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.63, we must say that CETX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.63, CETX is doing worse than 78.57% of the companies in the same industry.
CETX has a Debt/Equity ratio of 1.00. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CETX (1.00) is worse than 87.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z -0.63
ROIC/WACCN/A
WACC3.94%

2.3 Liquidity

CETX has a Current Ratio of 0.92. This is a bad value and indicates that CETX is not financially healthy enough and could expect problems in meeting its short term obligations.
CETX's Current ratio of 0.92 is on the low side compared to the rest of the industry. CETX is outperformed by 91.27% of its industry peers.
A Quick Ratio of 0.64 indicates that CETX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.64, CETX is doing worse than 88.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.64

6

3. Growth

3.1 Past

CETX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.94%, which is quite impressive.
CETX shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.98%.
The Revenue has been growing by 21.31% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)76.94%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q71.18%
Revenue 1Y (TTM)30.98%
Revenue growth 3Y10.92%
Revenue growth 5Y21.31%
Revenue growth Q2Q41%

3.2 Future

Based on estimates for the next years, CETX will show a very strong growth in Earnings Per Share. The EPS will grow by 31.92% on average per year.
Based on estimates for the next years, CETX will show a quite strong growth in Revenue. The Revenue will grow by 16.02% on average per year.
EPS Next Y81.31%
EPS Next 2Y44.26%
EPS Next 3Y31.92%
EPS Next 5YN/A
Revenue Next Year18.09%
Revenue Next 2Y16.53%
Revenue Next 3Y16.02%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 5.45, the valuation of CETX can be described as very cheap.
CETX's Price/Forward Earnings ratio is rather cheap when compared to the industry. CETX is cheaper than 97.62% of the companies in the same industry.
CETX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.27.
Industry RankSector Rank
PE N/A
Fwd PE 5.45

4.2 Price Multiples

CETX's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 47.04

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CETX's earnings are expected to grow with 31.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.26%
EPS Next 3Y31.92%

0

5. Dividend

5.1 Amount

CETX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CEMTREX INC

NASDAQ:CETX (4/18/2024, 7:00:00 PM)

3.06

+0.03 (+0.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.24M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.45
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.82%
ROE -65.85%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 43.14%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.92
Quick Ratio 0.64
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)76.94%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y81.31%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)30.98%
Revenue growth 3Y10.92%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y